
CB · NYSE
The consensus rating is Hold, supported by all 22 analysts in the supplied consensus, with a mean price target of $374. The low and high targets are unavailable, so the target distribution and its spread cannot be measured. No named analyst or firm-level target is supplied, preventing identification of the most or least bullish analyst. The evidence also provides no rating or target revisions during the past week, so revision direction is unavailable. The substantive disagreement is valuation versus operating momentum: Zacks points to disciplined underwriting, broad-based premium growth and rising investment income, while its headline frames the stock’s solid growth against a premium valuation. The consensus therefore indicates balanced views rather than a documented directional shift.